Release of macromolecules and daunomycin from hydrophilic gels containing enzymatically degradable bonds
- PMID: 1703786
- DOI: 10.1163/156856289x00145
Release of macromolecules and daunomycin from hydrophilic gels containing enzymatically degradable bonds
Abstract
The synthesis of hydrophilic gels based on N-(2-hydroxypropyl)methacrylamide copolymers crosslinked via degradable oligopeptide sequences is described. The influence of the conditions of preparation and of the gel structure on the equilibrium degree of swelling (network density) was determined. To evaluate the potential of such gels for controlled delivery of macromolecules and drugs, the release of FITC-dextrans of different molecular weights was studied and the rate of release was found to depend mainly on the equilibrium degree of swelling and not on the structure of the crosslinks. However, the degradation of the gels by a mixture of lysosomal enzymes isolated from rat liver (Tritosomes) or chymotrypsin was dependent on both the equilibrium degree of swelling and the structure of the crosslinks (length of the oligopeptide sequence and structure of the amino acid residues). The release of the anticancer drug daunomycin imbibed in gels was pH-dependent, the rate of release being higher at lower pH. In addition, a gel was synthesized which contained a pentapeptide in the crosslinks and daunomycin bound via a tetrapeptide side-chain, and in this case, incubation with Tritosomes led to degradation with simultaneous release of the drug.
Similar articles
-
Stability in rat plasma and serum of lysosomally degradable oligopeptide sequences in N-(2-hydroxypropyl) methacrylamide copolymers.Biomaterials. 1985 Jan;6(1):45-8. doi: 10.1016/0142-9612(85)90037-7. Biomaterials. 1985. PMID: 3971018
-
Degradable dextran hydrogels: controlled release of a model protein from cylinders and microspheres.J Control Release. 1999 Aug 5;60(2-3):211-21. doi: 10.1016/s0168-3659(99)00074-7. J Control Release. 1999. PMID: 10425327
-
Anticancer agents coupled to N-(2-hydroxypropyl)methacrylamide copolymers. I. Evaluation of daunomycin and puromycin conjugates in vitro.Br J Cancer. 1987 Feb;55(2):165-74. doi: 10.1038/bjc.1987.33. Br J Cancer. 1987. PMID: 3468994 Free PMC article.
-
Hydrogel-based drug delivery systems: comparison of drug diffusivity and release kinetics.J Control Release. 2010 Mar 3;142(2):221-8. doi: 10.1016/j.jconrel.2009.10.030. Epub 2009 Nov 1. J Control Release. 2010. PMID: 19887092
-
N-(2-hydroxypropyl)methacrylamide copolymers targeted to the hepatocyte galactose-receptor: pharmacokinetics in DBA2 mice.Br J Cancer. 1991 Jun;63(6):859-66. doi: 10.1038/bjc.1991.190. Br J Cancer. 1991. PMID: 1648946 Free PMC article.
Cited by
-
Synthesis and characterization of enzymatically degradable PEG-based peptide-containing hydrogels.Macromol Biosci. 2010 Apr 8;10(4):445-54. doi: 10.1002/mabi.200900295. Macromol Biosci. 2010. PMID: 20146210 Free PMC article.
-
Hydrophilic biomaterials: From crosslinked and self-assembled hydrogels to polymer-drug conjugates and drug-free macromolecular therapeutics.J Control Release. 2024 Sep;373:1-22. doi: 10.1016/j.jconrel.2024.05.012. Epub 2024 May 17. J Control Release. 2024. PMID: 38734315
-
The use of synthetic polymers for delivery of therapeutic antisense oligodeoxynucleotides.Biomaterials. 2002 Jan;23(2):321-42. doi: 10.1016/s0142-9612(01)00125-9. Biomaterials. 2002. PMID: 11761152 Free PMC article. Review.
-
Hydrogels for site-specific drug delivery to the colon: in vitro and in vivo degradation.Pharm Res. 1992 Dec;9(12):1540-5. doi: 10.1023/a:1015847921435. Pharm Res. 1992. PMID: 1488395
-
HPMA copolymers: origins, early developments, present, and future.Adv Drug Deliv Rev. 2010 Feb 17;62(2):122-49. doi: 10.1016/j.addr.2009.10.004. Epub 2009 Nov 14. Adv Drug Deliv Rev. 2010. PMID: 19919846 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources